Zealand Pharma A/S (ZEAL) — Cash Flow Reinvestment Rate
Zealand Pharma A/S (ZEAL) has a Cash Flow Reinvestment Rate of 0.19x as of June 2025, reinvesting Dkr1.58 Billion (capex Dkr6.73 Million plus investments Dkr-1.57 Billion) from operating cash flow of Dkr8.52 Billion. Check ZEAL cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zealand Pharma A/S Cash Flow Reinvestment Rate (2012–2025)
Historical reinvestment intensity for Zealand Pharma A/S across 3 annual periods. Explore ZEAL long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Zealand Pharma A/S (2012–2025)
Year-by-year capital reinvestment analysis for Zealand Pharma A/S. For live market cap and broader valuation context, see ZEAL stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (DKK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.01x | Dkr33.37 Million | Dkr6.53 Billion | Dkr33.37 Million | ▼ -99.9% |
| 2016 | 7.40x | Dkr302.56 Million | Dkr40.90 Million | Dkr2.60 Million | ▲ +5628.9% |
| 2012 | 0.13x | Dkr8.85 Million | Dkr68.54 Million | Dkr8.85 Million | — |